Wegovy FlexTouch 1.7mg (1 pen = 4 doses) – PREORDER

This product is available for pre-order only. Once your order is placed, we will procure the item directly from our supplier. Delivery may take additional time depending on availability. You will be notified via email with updates.

Wegovy FlexTouch 1.7mg marks the fourth and final titration step before reaching full maintenance therapy. Each pre-filled pen contains 4 weekly doses of 1.7mg, providing a gradual increase in exposure to semaglutide to ensure patient comfort and treatment adherence.

This stage helps reduce gastrointestinal side effects and prepares the body for the highest therapeutic dose. Semaglutide continues to act on appetite regulation and glucose metabolism, enabling consistent and sustainable weight loss.

Dose schedule:

• Weeks 1–4: 0.25mg

• Weeks 5–8: 0.5mg

• Weeks 9–12: 1mg

• Weeks 13–16: 1.7mg (this product)

• Week 17 onward: 2.4mg

FlexTouch technology ensures patient-friendly, once-weekly subcutaneous injections.

To be used under medical supervision.